Gene drive technology now represents a $5 trillion problem opportunity

Gene drive technology now represents a $5 trillion problem opportunity | now it's a $5 trillion problem right and and there's not we we have an interesting model to it

now it's a $5 trillion problem right and and there's not we we have an interesting model to it

Beneficiaries (23)

Adverse (5)

{
  "nia": false,
  "qty": "$5 trillion",
  "url": "https://www.youtube.com/watch?v=Goa6c6Qz__I",
  "mode": "FORECAST",
  "role": "Guest-CEO",
  "context": "you know now it's a $5 trillion problem right and and there's not we we have an interesting model to it and some proprietary technologies",
  "to_year": 2026,
  "verbatim": "now it's a $5 trillion problem right and and there's not we we have an interesting model to it",
  "conv_cues": "$5 trillion problem",
  "direction": "NUMERIC_TARGET",
  "from_year": 2026,
  "timeframe": "Current/near future",
  "conv_level": "MEDIUM",
  "milestones": [
    {
      "kind": "event",
      "label": "Gene drive technology now represents a $5 trillion problem opportunity",
      "status": "pending",
      "weight": 1,
      "ordinal": 0,
      "source_id": "245_022",
      "expected_date": "2026-06-16",
      "observed_date": null
    },
    {
      "kind": "llm_pre_event",
      "label": "Colossal Biosciences or Ben Lamm publicly announces gene-drive commercial business unit",
      "source": "https://colossal.com/news/",
      "status": "pending",
      "weight": 0.4,
      "ordinal": 1,
      "source_id": null,
      "confidence": 0.5,
      "expected_date": "2027-03-17",
      "research_origin": "training",
      "expected_date_range": {
        "to": "2027-12-31",
        "from": "2026-06-01"
      },
      "measurement_criterion": "Colossal Biosciences (or Ben Lamm via X/podcast/PR) publicly discloses a gene-drive commercial subsidiary, partnership, or service offering targeting biosecurity / pest control / conservation markets"
    },
    {
      "kind": "llm_pre_event",
      "label": "Gene-drive Phase III mosquito field trial starts in sub-Saharan Africa",
      "source": "https://www.gatesfoundation.org/our-work/places/africa/gene-drive-technology-faq",
      "status": "pending",
      "weight": 0.4,
      "ordinal": 2,
      "source_id": null,
      "confidence": 0.6,
      "expected_date": "2027-06-16",
      "research_origin": "training",
      "expected_date_range": {
        "to": "2028-06-30",
        "from": "2026-06-01"
      },
      "measurement_criterion": "Target Malaria, Imperial College London, or partner consortium begins Phase III gene-drive mosquito field deployment in named African country (Burkina Faso, Mali, Tanzania, etc.) with biosafety committee approval; confirmed via Target Malaria announcement, Nature paper, or BMGF press release"
    },
    {
      "kind": "llm_pre_event",
      "label": "International gene-drive governance framework formalized (Convention on Biological Diversity / WHO)",
      "source": "https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2023.1261123/full",
      "status": "pending",
      "weight": 0.4,
      "ordinal": 3,
      "source_id": null,
      "confidence": 0.4,
      "expected_date": "2027-12-16",
      "research_origin": "training",
      "expected_date_range": {
        "to": "2028-12-31",
        "from": "2026-12-01"
      },
      "measurement_criterion": "CBD COP, WHO, or UN body formally adopts framework for gene-drive deployment governance (decision document, formal resolution, or treaty addendum)"
    },
    {
      "kind": "llm_pre_event",
      "label": "First gene-drive-derived commercial product (mosquito control, agricultural pest control) ships",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10795774/",
      "status": "pending",
      "weight": 0.4,
      "ordinal": 4,
      "source_id": null,
      "confidence": 0.45,
      "expected_date": "2030-07-02",
      "research_origin": "training",
      "expected_date_range": {
        "to": "2032-12-31",
        "from": "2028-01-01"
      },
      "measurement_criterion": "First country grants commercial deployment authorization or first paying customer (NGO, government, or private) deploys gene-drive product for malaria, agricultural pest, or invasive-species control; confirmed via regulatory record or company
... (truncated)